• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

百日咳及经典疫苗的历史回顾

Historical review of pertussis and the classical vaccine.

作者信息

Cherry J D

机构信息

Department of Pediatrics, UCLA School of Medicine 90095, USA.

出版信息

J Infect Dis. 1996 Nov;174 Suppl 3:S259-63. doi: 10.1093/infdis/174.supplement_3.s259.

DOI:10.1093/infdis/174.supplement_3.s259
PMID:8896526
Abstract

Pertussis is an epidemic disease caused by Bordetella pertussis and also to a lesser extent by Bordetella parapertussis. Classical illness lasts 4-8 weeks and is characterized by paroxysms of coughing with posttussive vomiting and whooping; however, 47.4% of primary infections last 4 weeks or less. Whole cell pertussis vaccines are generally highly efficacious. All whole cell vaccines are reactogenic, causing fever and local reactions in many vaccinees. In the past, these vaccines were thought to cause infant deaths and brain damage. However, several large epidemiologic studies indicate that whole cell vaccines do not cause infant deaths or neurologic disease. Recent studies indicate that neither immunization nor infection give long-term immunity. As a result, B. pertussis infections are endemic in adult populations. The future control of B. pertussis will require immunization schedules with new acellular vaccines that include booster doses in older children and adults.

摘要

百日咳是一种由百日咳博德特氏菌引起的流行病,较少程度上也可由副百日咳博德特氏菌引起。典型病程持续4至8周,其特征为阵发性咳嗽伴咳嗽后呕吐及哮吼;然而,47.4%的原发性感染持续4周或更短时间。全细胞百日咳疫苗通常高度有效。所有全细胞疫苗都有反应原性,会使许多接种者出现发热和局部反应。过去,这些疫苗被认为会导致婴儿死亡和脑损伤。然而,几项大型流行病学研究表明,全细胞疫苗不会导致婴儿死亡或神经疾病。近期研究表明,免疫接种和感染都不会提供长期免疫力。因此,百日咳博德特氏菌感染在成年人群中呈地方性流行。未来对百日咳博德特氏菌的控制将需要采用新的无细胞疫苗免疫接种计划,包括对大龄儿童和成年人进行加强接种。

相似文献

1
Historical review of pertussis and the classical vaccine.百日咳及经典疫苗的历史回顾
J Infect Dis. 1996 Nov;174 Suppl 3:S259-63. doi: 10.1093/infdis/174.supplement_3.s259.
2
Pertussis: the trials and tribulations of old and new pertussis vaccines.
Vaccine. 1992;10(14):1033-8. doi: 10.1016/0264-410x(92)90113-x.
3
Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.全细胞百日咳疫苗和无细胞百日咳疫苗在小鼠模型中针对副百日咳博德特氏菌的效力
Vaccine. 2004 May 7;22(15-16):1892-8. doi: 10.1016/j.vaccine.2003.11.005.
4
Bordetella pertussis and pertussis vaccines.百日咳博德特氏菌和百日咳疫苗。
Clin Infect Dis. 2009 Nov 15;49(10):1565-9. doi: 10.1086/644733.
5
Re-emergence of pertussis: what are the solutions?百日咳再现:有何应对之策?
Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118.
6
Epidemiology and prevention of pertussis.
Curr Opin Pediatr. 1997 Feb;9(1):14-8. doi: 10.1097/00008480-199702000-00005.
7
Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.百日咳博德特氏菌、副百日咳博德特氏菌、疫苗与百日咳流行周期
Pathog Dis. 2015 Oct;73(7). doi: 10.1093/femspd/ftv055. Epub 2015 Aug 4.
8
Licensed pertussis vaccines in the United States. History and current state.美国的获许可的百日咳疫苗。历史与现状。
Hum Vaccin Immunother. 2014;10(9):2684-90. doi: 10.4161/hv.29576. Epub 2014 Nov 6.
9
Prevention of pertussis.百日咳的预防
Semin Respir Infect. 1989 Dec;4(4):284-92.
10
Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.1957 年至 2012 年英格兰和威尔士百日咳免疫接种和控制:历史回顾。
Euro Surveill. 2013 Sep 19;18(38):20587. doi: 10.2807/1560-7917.es2013.18.38.20587.

引用本文的文献

1
Genomic epidemiology and evolution of under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023.2020 - 2023年中国北京无细胞疫苗接种压力下的基因组流行病学及演变
Emerg Microbes Infect. 2025 Dec;14(1):2447611. doi: 10.1080/22221751.2024.2447611. Epub 2025 Jan 8.
2
Immunization with an mRNA DTP vaccine protects against pertussis in rats.接种 mRNA DTP 疫苗可预防大鼠百日咳。
Infect Immun. 2024 Aug 13;92(8):e0052023. doi: 10.1128/iai.00520-23. Epub 2024 Jul 17.
3
Resurgence of pertussis: reasons and coping strategies.
百日咳的再度流行:原因及应对策略
World J Pediatr. 2024 Jul;20(7):639-642. doi: 10.1007/s12519-024-00821-2. Epub 2024 Jul 2.
4
Antibody persistence to diphtheria toxoid, tetanus toxoid, antigens, and type b following primary and first booster with pentavalent versus hexavalent vaccines.在使用五价疫苗和六价疫苗进行基础免疫和首次加强免疫后,对白喉类毒素、破伤风类毒素、抗原和 b 型的抗体持久性。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2352909. doi: 10.1080/21645515.2024.2352909. Epub 2024 May 16.
5
Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy.青少年和儿童百日咳加强疫苗接种后的长期免疫原性与婴儿期初次疫苗接种的关系
Vaccines (Basel). 2022 Apr 28;10(5):693. doi: 10.3390/vaccines10050693.
6
Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination.年龄和初次疫苗接种背景影响浆细胞对百日咳加强疫苗接种的反应。
Vaccines (Basel). 2022 Jan 18;10(2):136. doi: 10.3390/vaccines10020136.
7
Genetic Diversity of Clinical ST2 Strains in comparison with Vaccine Reference Strains of India.与印度疫苗参考菌株相比,临床ST2菌株的遗传多样性
J Genomics. 2021 Sep 3;9:38-42. doi: 10.7150/jgen.58823. eCollection 2021.
8
Optimization of sample preparation for culture-independent sequencing of .优化用于非培养测序的样本制备。
Microb Genom. 2020 Mar;6(3). doi: 10.1099/mgen.0.000332.
9
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.测定无细胞百日咳疫苗中百日咳毒素活性的检测方法。
Toxins (Basel). 2019 Jul 17;11(7):417. doi: 10.3390/toxins11070417.
10
Investigation of temporal and spatial heterogeneities of the immune responses to infection in the lung and spleen of mice via analysis and modeling of dynamic microarray gene expression data.通过对动态微阵列基因表达数据的分析和建模,研究小鼠肺和脾中对感染的免疫反应的时空异质性。
Infect Dis Model. 2019 Jun 7;4:215-226. doi: 10.1016/j.idm.2019.06.001. eCollection 2019.